These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17900625)

  • 41. Relationships between ceruloplasmin and viral immunity.
    Samuel I; Tomas E
    Virologie; 1982; 33(1):63-72. PubMed ID: 6280375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Specificity of the zebrafish host transcriptome response to acute and chronic mycobacterial infection and the role of innate and adaptive immune components.
    van der Sar AM; Spaink HP; Zakrzewska A; Bitter W; Meijer AH
    Mol Immunol; 2009 Jul; 46(11-12):2317-32. PubMed ID: 19409617
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Viral infections of blood mononuclear cells and regulation of the immune response].
    Salonen R; Ilonen J; Salmi A
    Duodecim; 1990; 106(12):913-21. PubMed ID: 1670332
    [No Abstract]   [Full Text] [Related]  

  • 44. [Immune response to viral infection].
    Takahashi H
    Tanpakushitsu Kakusan Koso; 1992 Oct; 37(14 Suppl):2875-83. PubMed ID: 1438862
    [No Abstract]   [Full Text] [Related]  

  • 45. Increased virus replication in mammalian cells by blocking intracellular innate defense responses.
    de Vries W; Haasnoot J; van der Velden J; van Montfort T; Zorgdrager F; Paxton W; Cornelissen M; van Kuppeveld F; de Haan P; Berkhout B
    Gene Ther; 2008 Apr; 15(7):545-52. PubMed ID: 18273055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Viral infection in internally structured hosts. I. Conditions for persistent infection.
    Orive ME; Stearns MN; Kelly JK; Barfield M; Smith MS; Holt RD
    J Theor Biol; 2005 Feb; 232(4):453-66. PubMed ID: 15588629
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interactions of viruses with the immune system.
    Mims CA
    Clin Exp Immunol; 1986 Oct; 66(1):1-16. PubMed ID: 3542314
    [No Abstract]   [Full Text] [Related]  

  • 48. Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infections.
    Vassilopoulos D; Calabrese LH
    Curr Opin Rheumatol; 2007 Nov; 19(6):619-25. PubMed ID: 17917544
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modeling immune responses with handling time.
    Pilyugin SS; Antia R
    Bull Math Biol; 2000 Sep; 62(5):869-90. PubMed ID: 11016088
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Viral infection as a factor in the progressive divergence of the immune system in the course of evolution].
    Rodin SN; Matushkin IuG
    Zh Obshch Biol; 1987; 48(6):845-52. PubMed ID: 3439343
    [No Abstract]   [Full Text] [Related]  

  • 51. How molecular methods change our views of FeLV infection and vaccination.
    Hofmann-Lehmann R; Cattori V; Tandon R; Boretti FS; Meli ML; Riond B; Lutz H
    Vet Immunol Immunopathol; 2008 May; 123(1-2):119-23. PubMed ID: 18295346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Host-virus relations].
    Fischer A; Griscelli C
    Rev Prat; 1985 Oct; 35(47):2841-6. PubMed ID: 4089491
    [No Abstract]   [Full Text] [Related]  

  • 53. Global stability analysis of humoral immunity virus dynamics model including latently infected cells.
    Elaiw AM
    J Biol Dyn; 2015; 9():215-28. PubMed ID: 26145479
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of cancer immunotherapy outcome in terms of the immune response time features.
    Rodríguez-Pérez D; Sotolongo-Grau O; Espinosa Riquelme R; Sotolongo-Costa O; Santos Miranda JA; Antoranz JC
    Math Med Biol; 2007 Sep; 24(3):287-300. PubMed ID: 17652107
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A basic mathematical model of the immune response.
    Mayer H; Zaenker KS; An Der Heiden U
    Chaos; 1995 Mar; 5(1):155-161. PubMed ID: 12780168
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunity. II. Immune complex diseases.
    McNutt DR
    Rev Bras Pesqui Med Biol; 1974; 7(2):203-10. PubMed ID: 4277523
    [No Abstract]   [Full Text] [Related]  

  • 57. Role of latency period in viral infection: a pest control model.
    Ghosh S; Bhattacharyya S; Bhattacharya DK
    Math Biosci; 2007 Dec; 210(2):619-46. PubMed ID: 17767939
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Threshold dynamics of an HIV-1 model with both viral and cellular infections, cell-mediated and humoral immune responses.
    Lin J; Xu R; Tian X
    Math Biosci Eng; 2018 Dec; 16(1):292-319. PubMed ID: 30674121
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Latent and activated viral infections].
    Degré M
    Tidsskr Nor Laegeforen; 1990 Sep; 110(21):2747-8. PubMed ID: 2219044
    [No Abstract]   [Full Text] [Related]  

  • 60. [Immune response to microorganisms].
    Manzano Espinosa L; Rodríguez Zapata M; Alvarez-Mon Soto M
    Med Clin (Barc); 1999 Oct; 113(13):505-11. PubMed ID: 10604177
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.